All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Inventiva, Moleculin, Myrtelle, Optinose, Regenxbio.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alimera, Horizon, MGC, Puma, Siga.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Emergent, Entasis, F-star, Innoviva, La Jolla, Novavax, Rational, Ridgeback, Sino, Vertex.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Empowered Diagnostics.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Dexcom, Electrocore, Laseroptek, Medial Earlysign, Reflexion, Roche, Zillion.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adverum, Annovis, Bausch + Lomb, Clovis, Diamedica, Innocare, Pfizer, Xortx.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascletis, Biogen, Chinook, Coherus, Junshi, Inflarx, Kazia, Olix, Pyramid, Roche, Sensorion, Takeda, Titan, Turnstone.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Gnubiotics, Homology, Immunome, Intravacc, Kalvista, Kamada, Mnemo, Pfizer, Plakous, Ring, Roivant, Sollievo, Touchlight, Turnstone, Vast, Walden.
Oxford University has opened the doors to its new Pandemic Sciences Institute, a £100 million (US$119.5 million) initiative to build on the research and experience of COVID-19, to counter future pandemic threats.